In this issue of the Journal of Adolescent Health, Neilan and coauthors report the findings from their model-based costeffectiveness and clinical impact analysis to determine the optimal age (beginning at age 13 years) for routine one-time HIV screening among US adolescents and young adults without identified HIV risk factors. Read More
Explore Related Resources
sample caption 4
Fact Sheets
The Pediatric Treatment Gap
Published March 2026
View ResourceTopics:
HIV,
Pediatric HIV
Countries:
Global
Issue Briefs
Accelerating Progress to Ending Pediatric HIV
Published March 2026
We are at a critical inflection point for children affected by HIV. In 2024 alone, 120,000 children were newly infected, and, without timely treatment, half of HIV positive infants will not reach their second birthday. Children remain left behind—a child with HIV is 6 times more likely to die than an adult without timely diagnosis. […]
View Resource
Topics:
HIV,
Pediatric HIV
Countries:
Global
Malawi landscape
Journal Articles
Examining teen club attendance and viral load suppression among adolescents under differentiated HIV care in Malawi
Published January 2025
Background In Malawi, compared to adults, adolescents have higher rates of high HIV viremia and poorer antiretroviral therapy (ART) outcomes. The Ministry of Health, supported by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), implemented the provision of differentiated care clubs for adolescents living with HIV (ALHIV), called “teen clubs,” to provide psychosocial support and an […]
View Resource
Topics:
Adolescents
Countries:
Malawi